InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.09%
)
US TECH 100
19,304.80
(
0.47%
)
Dow Jones
39,164.06
(
0.09%
)
Brent Oil
85.49
(
0.08%
)
Bitcoin
61,977.27
(
0.59%
)
Post# of 97239
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Qui-Gon Kagi

Send PM Follow Ignore
Followers 19
Posts 3907
Boards Moderated 1
Alias Born 05/26/2004

Qui-Gon Kagi

Re: None

Tuesday, 10/30/2007 1:42:29 PM

Tuesday, October 30, 2007 1:42:29 PM

Post# of 97239
MACM - News! Delucia, ceo to "provide a company overview including its two priority product candidates: EcoNail(R), which is currently in a fully enrolled Phase 2 efficacy trial, and pexiganan, the Company's recently acquired novel topical anti-infective drug for treatment of diabetic foot infection (DFI)." at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference being held in NYC from Nov 5-7.

http://clearstation.etrade.com/cgi-bin/bbs?post_id=8376172&Refer=http://clearstation.etrade.com/

cmkxman
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up